Clinical and pharmacoeconomic aspects of anti-TNF therapy change for medical reasons

Abstract

The substitution of one drug for another within one class can be caused by both medical indications, such as low therapeutic efficacy, and by non-medical factors, for example, by choosing a less expensive drug. In this article, the available data on the impact of non-medical switching on the clinical and pharmacoeconomic indices of anti-TNF therapy with drugs are considered.

Keywords

• анти-фно терапия
• немедицинское переключение терапии
• биопрепараты
• биоаналоги
• anti-tnf therapy
• non-medical therapy switching
• biologics
• bioanalogs